Pathophysiological Role of Caveolae in Hypertension

Caveolae, flask-shaped cholesterol-, and glycosphingolipid-rich membrane microdomains, contain caveolin 1, 2, 3 and several structural proteins, in particular Cavin 1–4, EHD2, pacsin2, and dynamin 2. Caveolae participate in several physiological processes like lipid uptake, mechanosensitivity, or si...

Full description

Bibliographic Details
Main Authors: Xiaoming Lian, Claudia Matthaeus, Mario Kaßmann, Oliver Daumke, Maik Gollasch
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-07-01
Series:Frontiers in Medicine
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fmed.2019.00153/full
_version_ 1818367308567937024
author Xiaoming Lian
Claudia Matthaeus
Mario Kaßmann
Oliver Daumke
Maik Gollasch
Maik Gollasch
author_facet Xiaoming Lian
Claudia Matthaeus
Mario Kaßmann
Oliver Daumke
Maik Gollasch
Maik Gollasch
author_sort Xiaoming Lian
collection DOAJ
description Caveolae, flask-shaped cholesterol-, and glycosphingolipid-rich membrane microdomains, contain caveolin 1, 2, 3 and several structural proteins, in particular Cavin 1–4, EHD2, pacsin2, and dynamin 2. Caveolae participate in several physiological processes like lipid uptake, mechanosensitivity, or signaling events and are involved in pathophysiological changes in the cardiovascular system. They serve as a specific membrane platform for a diverse set of signaling molecules like endothelial nitric oxide synthase (eNOS), and further maintain vascular homeostasis. Lack of caveolins causes the complete loss of caveolae; induces vascular disorders, endothelial dysfunction, and impaired myogenic tone; and alters numerous cellular processes, which all contribute to an increased risk for hypertension. This brief review describes our current knowledge on caveolae in vasculature, with special focus on their pathophysiological role in hypertension.
first_indexed 2024-12-13T22:49:59Z
format Article
id doaj.art-53bd258f886645a6bbca46dd23965a8a
institution Directory Open Access Journal
issn 2296-858X
language English
last_indexed 2024-12-13T22:49:59Z
publishDate 2019-07-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Medicine
spelling doaj.art-53bd258f886645a6bbca46dd23965a8a2022-12-21T23:28:39ZengFrontiers Media S.A.Frontiers in Medicine2296-858X2019-07-01610.3389/fmed.2019.00153451115Pathophysiological Role of Caveolae in HypertensionXiaoming Lian0Claudia Matthaeus1Mario Kaßmann2Oliver Daumke3Maik Gollasch4Maik Gollasch5Experimental and Clinical Research Center—A Joint Cooperation Between the Charité–University Medicine Berlin and the Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, GermanyMax Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, GermanyExperimental and Clinical Research Center—A Joint Cooperation Between the Charité–University Medicine Berlin and the Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, GermanyMax Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, GermanyExperimental and Clinical Research Center—A Joint Cooperation Between the Charité–University Medicine Berlin and the Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, GermanyMedical Clinic for Nephrology and Internal Intensive Care, Berlin, GermanyCaveolae, flask-shaped cholesterol-, and glycosphingolipid-rich membrane microdomains, contain caveolin 1, 2, 3 and several structural proteins, in particular Cavin 1–4, EHD2, pacsin2, and dynamin 2. Caveolae participate in several physiological processes like lipid uptake, mechanosensitivity, or signaling events and are involved in pathophysiological changes in the cardiovascular system. They serve as a specific membrane platform for a diverse set of signaling molecules like endothelial nitric oxide synthase (eNOS), and further maintain vascular homeostasis. Lack of caveolins causes the complete loss of caveolae; induces vascular disorders, endothelial dysfunction, and impaired myogenic tone; and alters numerous cellular processes, which all contribute to an increased risk for hypertension. This brief review describes our current knowledge on caveolae in vasculature, with special focus on their pathophysiological role in hypertension.https://www.frontiersin.org/article/10.3389/fmed.2019.00153/fullcaveolaecaveolin 1endothelial nitric oxide synthaseCa2+ channelshypertension
spellingShingle Xiaoming Lian
Claudia Matthaeus
Mario Kaßmann
Oliver Daumke
Maik Gollasch
Maik Gollasch
Pathophysiological Role of Caveolae in Hypertension
Frontiers in Medicine
caveolae
caveolin 1
endothelial nitric oxide synthase
Ca2+ channels
hypertension
title Pathophysiological Role of Caveolae in Hypertension
title_full Pathophysiological Role of Caveolae in Hypertension
title_fullStr Pathophysiological Role of Caveolae in Hypertension
title_full_unstemmed Pathophysiological Role of Caveolae in Hypertension
title_short Pathophysiological Role of Caveolae in Hypertension
title_sort pathophysiological role of caveolae in hypertension
topic caveolae
caveolin 1
endothelial nitric oxide synthase
Ca2+ channels
hypertension
url https://www.frontiersin.org/article/10.3389/fmed.2019.00153/full
work_keys_str_mv AT xiaominglian pathophysiologicalroleofcaveolaeinhypertension
AT claudiamatthaeus pathophysiologicalroleofcaveolaeinhypertension
AT mariokaßmann pathophysiologicalroleofcaveolaeinhypertension
AT oliverdaumke pathophysiologicalroleofcaveolaeinhypertension
AT maikgollasch pathophysiologicalroleofcaveolaeinhypertension
AT maikgollasch pathophysiologicalroleofcaveolaeinhypertension